How Immunotherapy Is Rewriting the Rules of Liver Cancer Treatment
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A two-decade bibliometric analysis of nearly 5,000 studies maps how small molecule drug research transformed lung cancer therapy, revealing China's ...
A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...
A 14-year Thai study of 218 children found that colistin-based combination therapy improved bacterial clearance but did not reduce mortality, ...
Researchers have combined IR780-paclitaxel albumin nanoparticles with acriflavine-releasing hydrogels to simultaneously block hypoxia-inducible factor 1 and heat shock protein 70, ...
A post hoc analysis of the SCHOLAR study found that over 42 percent of Chinese adults starting semaglutide also took ...
Boston Children's Hospital researchers discovered that the metabolic enzyme FAH moves into the nucleus of breast cancer cells and drives ...
Three commercially approved metabolism-targeting drugs—pioglitazone, melatonin and insulin—improved survival, motor function, muscle size and hepatic pathology in Smn2B/- spinal muscular ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
A Swedish prospective study shows that the hyperemic zone surrounding microwave-ablated liver tumors is arterially supplied and peaks in intensity ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine